Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-236834
Filing Date
2026-05-22
Accepted
2026-05-22 16:04:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d151872ddefa14a.htm DEFA14A 17110
  Complete submission text file 0001193125-26-236834.txt   18123
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39980 | Film No.: 261013580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)